Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.

[1]  Micah L. Burch,et al.  Overexpression of sphingosine kinase 1 in liver reduces triglyceride content in mice fed a low but not high-fat diet. , 2015, Biochimica et biophysica acta.

[2]  G. Shulman,et al.  Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids , 2015, Proceedings of the National Academy of Sciences.

[3]  Todd Evans,et al.  Sphingosine 1-phosphate signalling , 2014, Development.

[4]  M. Vadas,et al.  Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic β‐cell death in diet‐induced obese mice , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  D. Sabatini,et al.  Regulation of mTORC1 and its impact on gene expression at a glance , 2013, Journal of Cell Science.

[6]  P. Meikle,et al.  Overexpression of Sphingosine Kinase 1 Prevents Ceramide Accumulation and Ameliorates Muscle Insulin Resistance in High-Fat Diet–Fed Mice , 2012, Diabetes.

[7]  A. Dannenberg,et al.  Sphingolipid signaling in metabolic disorders. , 2012, Cell metabolism.

[8]  A. Franco‐Cereceda,et al.  Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue , 2012, Lipids in Health and Disease.

[9]  Y. Barak,et al.  Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[11]  J. Whitehead.  Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra. , 2011, The international journal of biochemistry & cell biology.

[12]  S. Miura,et al.  An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat. , 2011, The Journal of nutritional biochemistry.

[13]  D. Brenner,et al.  Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  B. Neuschwander‐Tetri,et al.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.

[15]  L. Videla,et al.  Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. , 2011, The Journal of clinical endocrinology and metabolism.

[16]  S. Pitson.  Regulation of sphingosine kinase and sphingolipid signaling. , 2011, Trends in biochemical sciences.

[17]  B. Neuschwander‐Tetri.  Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites , 2010, Hepatology.

[18]  Elizabeth M. Brunt,et al.  Pathology of nonalcoholic fatty liver disease , 2010, Nature Reviews Gastroenterology &Hepatology.

[19]  S. Kersten,et al.  Kupffer cells promote hepatic steatosis via interleukin‐1β–dependent suppression of peroxisome proliferator‐activated receptor α activity , 2010, Hepatology.

[20]  R. Proia,et al.  Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver* , 2010, The Journal of Biological Chemistry.

[21]  Wei Hu,et al.  Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity[S] , 2009, Journal of Lipid Research.

[22]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[23]  Andrew S. Holmes,et al.  Tumor necrosis factor-like weak inducer of apoptosis attenuates the action of insulin in hepatocytes. , 2008, Endocrinology.

[24]  Laxman Yetukuri,et al.  PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism , 2007, PLoS genetics.

[25]  W. Walsh,et al.  BMP-7 and CBFA1 in allograft bone in vivo bone formation and the influence of γ-irradiation , 2007 .

[26]  H. Duan,et al.  Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in KK/Ay diabetic mice , 2007, Diabetologia.

[27]  Andrew S. Holmes,et al.  Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1 , 2006, The Journal of cell biology.

[28]  R. Proia,et al.  Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720* , 2004, Journal of Biological Chemistry.

[29]  J. Hoofnagle,et al.  A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis , 2004, Hepatology.

[30]  B. Neuschwander‐Tetri,et al.  Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone , 2003, Hepatology.

[31]  M. Reitman,et al.  Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass* , 2003, Journal of Biological Chemistry.

[32]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[33]  B. Brewer,et al.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. , 2003, The Journal of clinical investigation.

[34]  U. Boelsterli,et al.  Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. , 2001, Journal of hepatology.

[35]  I. Rusyn,et al.  Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. , 2000, Carcinogenesis.

[36]  M. Pittenger,et al.  Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein Kinase* , 2000, The Journal of Biological Chemistry.

[37]  Sarah Spiegel,et al.  Sphingosine-1-phosphate signaling and its role in disease. , 2012, Trends in cell biology.

[38]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[39]  G. Musso,et al.  Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). , 2009, Progress in lipid research.